Average Co-Inventor Count = 6.44
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-La Roche Inc. (34 from 4,948 patents)
2. Chugai Seiyaku Kabushiki Kaisha (2 from 950 patents)
3. F. Hoffmann-La Roche Ag (2 from 168 patents)
36 patents:
1. RE49481 - Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
2. 11180525 - Process for making 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2, 7-dione compounds useful for the treatment of virus infection
3. 11046671 - Dihydropyrimidinyl benzazepine carboxamide compounds
4. 10975098 - Substituted aminothiazolopyrimidinediones for the treatment of virus infection
5. 10913745 - Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors
6. 10849881 - Octahydro-cyclobuta[1,2-c;3,4-c']dipyrrol-2-yl
7. 10669268 - Bicyclic derivatives
8. 10618929 - 3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2, 7-dione compounds for the treatment and prophylaxis of virus infection
9. 10590112 - Dihydropyrimidinyl benzazepine carboxamide compounds
10. 10590146 - Substituted aminothiazolopyrimidinediones
11. 10544102 - Benzazepine dicarboxamide compounds with secondary amide function
12. 10428027 - Sulfinylphenyl or sulfonimidoylphenyl benzazepines
13. 10370338 - Benzazepine dicarboxamide compounds with tertiary amide function
14. 10189838 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
15. 10065973 - Substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection